OBJECTIVE: To analyze the outcome of inborn preterm neonates with respiratory-distress-syndrome (RDS), using the approach of administering nasal-continuous-positive-airway-pressure (CPAP) alone and administering surfactant only if they require mechanical ventilation (MV). METHODS: All preterm neonates diagnosed as RDS from 01-May-2006 to 10-July-2010 were prospectively enrolled for the study at a referral centre in India. Nasal-CPAP alone was administered to all spontaneously breathing neonates. Surfactant was administered in babies <28 wk gestational age if the baby was intubated for resuscitation at birth. For the remaining babies, surfactant was administered if the baby required ventilation for RDS in first 72 h. The primary outcome assessed was survival to discharge. RESULTS: Of the 83 babies with RDS, 33(39.76%) neonates needed MV of which one baby was transferred due to non-availability of ventilator. Of the remaining 32 babies administered MV, 31 were administered surfactant. Fifty (61.24%) babies were managed with CPAP alone. Overall, 72/82(87.8%) babies managed at the authors' center survived the neonatal period, and 71/82(86.8%) babies were discharged to home. Among the neonates who were ventilated, 26/32(81.25%) survived the neonatal period, and 25/32(78.12%) were discharged home. Among the babies receiving CPAP, 46/50(92%) survived and were discharged to home. CONCLUSIONS: Institution of CPAP alone in all spontaneously breathing preterm babies with RDS and administration of surfactant to only those needing MV reduces the need for intubations and surfactant administration without affecting the outcome adversely. Extreme preterms with RDS, however, may be given surfactant if they happen to be intubated for resuscitation at birth.
OBJECTIVE: To analyze the outcome of inborn preterm neonates with respiratory-distress-syndrome (RDS), using the approach of administering nasal-continuous-positive-airway-pressure (CPAP) alone and administering surfactant only if they require mechanical ventilation (MV). METHODS: All preterm neonates diagnosed as RDS from 01-May-2006 to 10-July-2010 were prospectively enrolled for the study at a referral centre in India. Nasal-CPAP alone was administered to all spontaneously breathing neonates. Surfactant was administered in babies <28 wk gestational age if the baby was intubated for resuscitation at birth. For the remaining babies, surfactant was administered if the baby required ventilation for RDS in first 72 h. The primary outcome assessed was survival to discharge. RESULTS: Of the 83 babies with RDS, 33(39.76%) neonates needed MV of which one baby was transferred due to non-availability of ventilator. Of the remaining 32 babies administered MV, 31 were administered surfactant. Fifty (61.24%) babies were managed with CPAP alone. Overall, 72/82(87.8%) babies managed at the authors' center survived the neonatal period, and 71/82(86.8%) babies were discharged to home. Among the neonates who were ventilated, 26/32(81.25%) survived the neonatal period, and 25/32(78.12%) were discharged home. Among the babies receiving CPAP, 46/50(92%) survived and were discharged to home. CONCLUSIONS: Institution of CPAP alone in all spontaneously breathing preterm babies with RDS and administration of surfactant to only those needing MV reduces the need for intubations and surfactant administration without affecting the outcome adversely. Extreme preterms with RDS, however, may be given surfactant if they happen to be intubated for resuscitation at birth.
Authors: David G Sweet; Virgilio Carnielli; Gorm Greisen; Mikko Hallman; Eren Ozek; Richard Plavka; Ola D Saugstad; Umberto Simeoni; Christian P Speer; Henry L Halliday Journal: Neonatology Date: 2010-06-10 Impact factor: 4.035
Authors: Barbara J Stoll; Nellie I Hansen; Edward F Bell; Seetha Shankaran; Abbot R Laptook; Michele C Walsh; Ellen C Hale; Nancy S Newman; Kurt Schibler; Waldemar A Carlo; Kathleen A Kennedy; Brenda B Poindexter; Neil N Finer; Richard A Ehrenkranz; Shahnaz Duara; Pablo J Sánchez; T Michael O'Shea; Ronald N Goldberg; Krisa P Van Meurs; Roger G Faix; Dale L Phelps; Ivan D Frantz; Kristi L Watterberg; Shampa Saha; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2010-08-23 Impact factor: 7.124
Authors: R A Ehrenkranz; N Younes; J A Lemons; A A Fanaroff; E F Donovan; L L Wright; V Katsikiotis; J E Tyson; W Oh; S Shankaran; C R Bauer; S B Korones; B J Stoll; D K Stevenson; L A Papile Journal: Pediatrics Date: 1999-08 Impact factor: 7.124
Authors: H Verder; P Albertsen; F Ebbesen; G Greisen; B Robertson; A Bertelsen; L Agertoft; B Djernes; E Nathan; J Reinholdt Journal: Pediatrics Date: 1999-02 Impact factor: 7.124
Authors: Neil N Finer; Waldemar A Carlo; Michele C Walsh; Wade Rich; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Abhik Das; W Kenneth Poole; Edward F Donovan; Nancy S Newman; Namasivayam Ambalavanan; Ivan D Frantz; Susie Buchter; Pablo J Sánchez; Kathleen A Kennedy; Nirupama Laroia; Brenda B Poindexter; C Michael Cotten; Krisa P Van Meurs; Shahnaz Duara; Vivek Narendran; Beena G Sood; T Michael O'Shea; Edward F Bell; Vineet Bhandari; Kristi L Watterberg; Rosemary D Higgins Journal: N Engl J Med Date: 2010-05-16 Impact factor: 91.245
Authors: Juan Emmanuel Dewez; Sushma Nangia; Harish Chellani; Sarah White; Matthews Mathai; Nynke van den Broek Journal: BMJ Open Date: 2020-02-28 Impact factor: 2.692